Cointime

  • 快讯
  • 头条
  • 行情
  • 专栏
  • 活动
  • 比特币 ¥559,245.60 -1.34%
  • 以太坊 ¥17,698.13 -1.47%
  • 币安币 ¥5,141.75 -4.95%
  • Optimism ¥0.70 -6.73%
  • Arbitrum ¥1.07 -12.32%
  • Solana ¥726.71 -3.12%
  • Polygon ¥1.56 +2.77%
  • Cosmos ¥13.09 -1.53%
  • Avalanche ¥55.89 -2.73%
  • 比特币 ¥559,245.60 -1.34%
  • 以太坊 ¥17,698.13 -1.47%
  • 币安币 ¥5,141.75 -4.95%
  • Optimism ¥0.70 -6.73%
  • Arbitrum ¥1.07 -12.32%
  • Solana ¥726.71 -3.12%
  • Polygon ¥1.56 +2.77%
  • Cosmos ¥13.09 -1.53%
  • Avalanche ¥55.89 -2.73%
Home / Blueprint Medicines / investors

Blueprint Medicines

company

Investors

Number of Lead Investors
Number of Investors
4
15
Blueprint Medicines is funded by 15 investors. Partner Fund Management and Eight Roads Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Partner Fund Management Yes Series C
Eight Roads Ventures Yes Series Unknown
Casdin Capital - Series C
Cowen Group - Series C
Fidelity Biosciences - Series C
Nextech Invest - Series C
Perceptive Advisors - Series C
RA Capital Management - Series C
Redmile Group - Series C
Sabby Capital - Series C
Tavistock Life Sciences - Series C
Third Rock Ventures - Series C
Wellington Management - Series C
Biotechnology Value Fund - Series B
F-Prime Capital - Series B

Contact

Cambridge,Massachusetts,United States
617-374-7580
Cointime
头条
  • 即时新闻
  • 全球政策
  • 比特币
  • 以太坊
  • 狗狗币
  • 区块链
  • 元宇宙
  • 区块链游戏
  • Web3
  • DeFi
  • NFT
热点
  • 项目报道
  • 行业洞见
  • 新闻
  • 教程
  • 政策解读
  • 专题
  • 专栏
  • 行情
  • 活动
  • 标签
RSS
  • 即时新闻
  • 头条
公司
  • 关于我们
  • 广告合作
  • 免责声明
  • © 2023 Cointime. 版权所有
  • 隐私政策
  • 服务条款